|
USP33 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.26585417095748E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.05180003490335E-09 |
| Normal-vs-Stage2 |
1.35310000004552E-06 |
| Normal-vs-Stage3 |
1.59539048638635E-13 |
| Normal-vs-Stage4 |
3.59257068538454E-12 |
| Stage1-vs-Stage2 |
9.593400E-01 |
| Stage1-vs-Stage3 |
2.178500E-03 |
| Stage1-vs-Stage4 |
7.586700E-04 |
| Stage2-vs-Stage3 |
3.819600E-02 |
| Stage2-vs-Stage4 |
7.522600E-03 |
| Stage3-vs-Stage4 |
3.810800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.48450174164827E-14 |
| Normal-vs-AfricanAmerican |
3.681099999997E-05 |
| Normal-vs-Asian |
2.079300E-03 |
| Caucasian-vs-AfricanAmerican |
4.812200E-01 |
| Caucasian-vs-Asian |
1.381750E-03 |
| AfricanAmerican-vs-Asian |
1.777590E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65720004385861E-09 |
| Normal-vs-Female |
3.91631171936524E-12 |
| Male-vs-Female |
7.259000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.15280000387597E-08 |
| Normal-vs-Age(41-60Yrs) |
3.13848946831286E-12 |
| Normal-vs-Age(61-80Yrs) |
5.01743091518847E-12 |
| Normal-vs-Age(81-100Yrs) |
2.992300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.009500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.202100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.015400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.818200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.576000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.826600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.782000E-04 |
| Classical-VS-Follicular |
5.255100E-03 |
| Classical-VS-Other |
7.496000E-01 |
| Classical-VS-Normal |
4.97949459443703E-11 |
| Tall-VS-Follicular |
3.29749999972151E-07 |
| Tall-VS-Other |
2.961800E-02 |
| Tall-VS-Normal |
2.19302354054207E-12 |
| Follicular-VS-Other |
5.642000E-01 |
| Follicular-VS-Normal |
3.226000E-04 |
| Other-VS-Normal |
1.561540E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.74199585048996E-11 |
| Normal-vs-N1 |
2.42229999947163E-07 |
| N0-vs-N1 |
3.959800E-01 |
|
|
